Visit https://www.peervoice.com/ZFT860 to view the entire programme with slides. After completing “Biologics and Beyond in Atopic Dermatitis: Emerging Targets and How They Work”, participants will be able to: Define the key goals of therapy for patients with moderate-to-severe atopic dermatitis (AD); Describe the limitations of current biologic therapies; Identify the therapeutic targets that are being assessed in clinical development for moderate-to-severe AD.